Atrium Therapeutics (RNA) Q1 2023 Earnings

May 23Confirmed
Aug 2022
Nov 2022
Q4 2022
Q1 2023
-0.93
-0.87
-0.8
-0.74

Details

Expected EPS
-0.85
Actual EPS
-0.74
Surprise EPS
0.11
Surprise Percent
+12.94%

Description

⁨Atrium Therapeutics⁩ (⁦RNA⁩) has reported earnings of ⁦-0.74⁩ per share for ⁦Q1 2023⁩.

0 Comments

Share your thoughts